Skip to main content
Non-Oil GDP Share: 55% 2025 real GDP |Saudi Unemployment: 7.2% Q4 2025 |PIF AUM: $1.21T 2025 actual |FDI Share of GDP: 2.8% Q1 2026 |Female Participation: 33.9% Q1 2026 |Credit Rating: Aa3/A+/A+ Moody's/Fitch/S&P |GDP Growth: 4.5% 2025 actual |Umrah Pilgrims: 18M+ 2025 foreign |Non-Oil GDP Share: 55% 2025 real GDP |Saudi Unemployment: 7.2% Q4 2025 |PIF AUM: $1.21T 2025 actual |FDI Share of GDP: 2.8% Q1 2026 |Female Participation: 33.9% Q1 2026 |Credit Rating: Aa3/A+/A+ Moody's/Fitch/S&P |GDP Growth: 4.5% 2025 actual |Umrah Pilgrims: 18M+ 2025 foreign |

Pharmaceuticals

Saudi Arabia and France Signed a Health AI, Pharma and Clinical-Trials Framework. No Investment Package Was Disclosed.

The bilateral MoU spans eight health workstreams and a separate Sanofi research framework, but names no budget, manufacturing project, trial or hospital deployment.

Updated Sep 1, 2026

Biotech and Life Sciences Investment

Guide to biotech and life sciences investment in Saudi Arabia covering pharma manufacturing, genomics, and medical devices.

Updated Apr 18, 2026

Healthcare Private Investment

Guide to private healthcare investment in Saudi Arabia covering hospitals, clinics, medical devices, and digital health.

Updated Apr 18, 2026

Manufacturing

Industrial cities, Made in Saudi initiatives, and localisation programmes advancing Vision 2030 goals.

Updated Apr 18, 2026

National Industry Strategy: Building Saudi Arabia's Manufacturing Base

An institutional analysis of Saudi Arabia's National Industry Strategy, examining the development of 36 industrial cities under MODON, manufacturing diversification into automotive, electronics, pharmaceuticals, and military industries, and the adoption of Fourth Industrial Revolution technologies.

Updated Apr 18, 2026

Saudi Healthcare Companies

Overview of Saudi Arabia's private healthcare sector, covering leading hospital groups, pharmaceutical companies, medical technology firms, health insurance providers, and the growth drivers under the Health Sector Transformation Program.

Updated Apr 18, 2026

Saudi Pharmaceutical Manufacturing

A detailed examination of Saudi Arabia's pharmaceutical manufacturing sector, covering localisation targets, key producers, regulatory developments, and the strategic alignment with Vision 2030's healthcare and [industrial diversification](/sectors/) objectives.

Updated Apr 18, 2026

Saudi Pharmaceutical Manufacturing: Local Production Capacity and Health Security Strategy

Analysis of Saudi Arabia's pharmaceutical manufacturing covering local production, vaccine capacity, and health security.

Updated Apr 18, 2026